π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This study was a single-center, randomized, double-blind, placebo-controlle...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2016-11-08
Trial ID
NCT06190340
Treatments Being Tested
This is an open-label, single dose, Phase 1 study conducted at a single stu...
Status
Completed
Location
Pharmaron Clinical Pharmacology Center
Start Date
2021-10-16
Trial ID
NCT05074134
Treatments Being Tested
A phase 1, single-center, double-blind, randomized, placebo-controlled clin...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2017-10-10
Trial ID
NCT06337604
Treatments Being Tested
This is a phase 1, single-center, randomized, double-blind, placebo-control...
Status
Completed
Location
Huashan Hospital Affiliated to Fudan University
Start Date
2022-07-07
Trial ID
NCT06394518
Treatments Being Tested
The aim of this study was to evaluate the safety, tolerability, and pharmac...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2020-08-27
Trial ID
NCT06135675
Treatments Being Tested
This study will investigate TNP-2092 distribution into joint tissues in par...
Status
Completed
Location
Rothman Orthopedic Institute
Start Date
2021-03-01
Trial ID
NCT04294862
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, pharmacokine...
Status
Completed
Location
eStudy Site
Start Date
2019-04-20
Trial ID
NCT03964493
Treatments Being Tested
This is a Phase 1/2, randomized, controlled, open-label, proof-of-concept s...
Status
Recruiting
Location
The First Affiliated Hospital of Xinjiang Medical University
Start Date
2025-04-03
Trial ID
NCT06889701
The aim of the study was to evaluate the tolerability and pharmacokinetic c...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2016-06-06
Trial ID
NCT06178718
Treatments Being Tested